文献速递免疫规划卫生政策与健康促进

若移动技术禁止未接种者进入公共场所,中国民众的新冠疫苗接种意愿会提高吗?一项全国离散选择实验

Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China.
PubMed 文献 · Vaccine · 2021-10-22

2020年8月在中国成人中开展在线离散选择实验,共873人完成4317个选择集。基于「健康码」的疫苗强制令使疫苗犹豫者选择「不接种」的预测概率从17.3%降至8.6%,但当疫苗效力低于60%时该强制令可能不提高接种意愿。

要点

  • 29.8%的参与者被识别为疫苗犹豫者(不确定或不愿意接种新冠疫苗)。
  • 基于健康码的强制令使疫苗犹豫者选择不接种的预测概率从17.3%降至8.6%。
  • 当疫苗效力大于60%时,基于健康码的强制令显著提高接种意愿。

核心结论

  • 在受教育程度较高的疫苗犹豫者中,若基于移动技术的疫苗强制令禁止未接种者进入公共场所和公共交通,接种新冠疫苗的意愿似乎会增加;但如果感知的疫苗效力低,此类强制令可能不会提高接种意愿。

研究设计与样本

  • 2020年8月在中国居民中开展在线离散选择实验(DCE),参与者完成最多六个选择集,每个选择集包含两个假设的新冠疫苗接种情景和一个「不接种」选项。
  • 共873名参与者完成4317个选择集,大多数参与者至少具有大学教育水平(90.9%)。
  • 半数选择集设置了「健康码」属性,将「不接种」选项与意味着出行受限的黄色健康码相关联。
  • 采用加权混合效应多项logit回归估计偏好效用和预测选择概率。

主要发现

  • 29.8%的参与者被识别为疫苗犹豫者(定义为不确定或不愿意接种新冠疫苗)。
  • 在有和无基于健康码的疫苗强制令时,疫苗犹豫者选择「不接种」而非中国当前常见接种情景(免费、国产疫苗、80%效力、10%发热副作用概率、大型医院接种、两剂次)的预测概率分别为8.6%(85%CI:6.4%-10.92%)和17.3%(85%CI:13.1%-21.6%)。
  • 无疫苗犹豫表现者对应的预测概率分别为0.3%(93%CI:0.0%-14.3%)和3.5%(93%CI:2.3%-4.8%)。
  • 当疫苗效力大于60%时,基于健康码的强制令显著提高接种意愿。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Achieving COVID-19 community protection (aka, herd immunity) in China may be challenging because many individuals remain unsure or are unwilling to be vaccinated. One potential means to increase COVID-19 vaccine uptake is to essentially mandate vaccination by using existing mobile technologies that can prohibit unvaccinated individuals from certain public spaces. The "Health Code" is a ubiquitous mobile phone app in China that regulates freedom of travel based on individuals' predicted risk of exposure to SARS-CoV-2. Green-colored codes indicate ability to travel unrestricted in low-risk regions; yellow-colored codes indicate prohibition from major public spaces and modes of public transportation. We examined the effects of a "Health Code"-based vaccine mandate on willingness to vaccinate for COVID-19 in China. METHODS: In August 2020, an online discrete choice experiment (DCE) was conducted among adults living in China. Participants completed up to six DCE choice sets, each containing two hypothetical COVID-19 vaccination scenario choices and a "do not vaccinate" choice. Half of the choice sets had a "Health Code" attribute that associated the "do not vaccinate" choice with a yellow Health Code implying restricted travel. Weighted, mixed effects multinomial logit regression was used to estimate preference utilities and predicted choice probabilities. RESULTS: Overall, 873 participants completed 4317 choice sets. Most participants attained at least college-level education (90.9%). 29.8% of participants were identified as vaccine hesitators (defined as being unsure or unwilling to receive a COVID-19 vaccination). With and without the "Health Code"-based vaccine mandate, there was an 8.6% (85% CI: 6.4% - 10.92%) and 17.3% (85% CI:13.1% - 21.6%) respective predicted probability that vaccine hesitators would choose "do not vaccinate" over a common vaccination scenario currently in China (i.e., free, domestic vaccine, 80% effectiveness, 10% probability of fever side-effects, administered in a large hospital, two doses). Corresponding predicted probabilities for people who did not express vaccine hesitancy was 0.3% (93% CI: 0.0% - 14.3%) and 3.5% (93% CI:2.3% - 4.8%). The "Health Code"-based mandate significantly increased willingness to vaccinate when vaccine efficacy was greater than 60%. CONCLUSION: Among vaccine hesitators with higher educational attainment, willingness to vaccinate for COVID-19 appears to increase if mobile technology-based vaccine mandates prohibit unvaccinated individuals from public spaces and public transportation. However, such mandates may not increase willingness if perceived vaccine efficacy is low.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wang J, Wagner AL, Chen Y, et al. Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China. Vaccine. 2021. PMID: 34742594. doi:10.1016/j.vaccine.2021.10.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。